We also know that each stem cell type can exist in many different “states” and this is critical to their function. NeoGenesis, unlike any other therapeutics company, uses our patented S²RM® technology in our products. This is a technology whereby specific combinations of stem cell types, with each type cultured under specific state-dependent conditions is formulated into each of our products. Using cell types and states that are relevant to the particular tissue and indication creates a unique set of molecules from multiple stem cell types called S²RM® that is complete and fully formed thereby rendering maximum therapeutic benefit.
What this means is that we culture the stem cells so that the molecules are fully processed and released by the cell. This allows the S²RM® molecules to be complete, in their natural form, and to be packaged into exosomes – the body’s own protective nano-sphere (a “smart” liposome) that provides targeting and delivery characteristics to the S²RM®. For example, the proteins in S²RM® are folded in their native 3-dimensional configuration, have all of their native moiety groups attached, and are packaged into the exosomes for the purposes of protection, targeting, and delivery to surrounding cells. The complete set of molecules, all of which are fully formed, work significantly better than the technology used by other companies, where malformed and incomplete sets of molecules are used to develop their products.